Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): NZ-$0.80

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.59. In 2024 the company made an earnings per share (EPS) of NZ$2.02 a decrease over its 2023 EPS that were of NZ$6.14.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.80-139.44%
2024NZ$2.02-67.16%
2023NZ$6.14-199.64%
2022NZ-$6.1699.03%
2021NZ-$3.10-68.98%
2020NZ-$9.99-298.06%
2019NZ$5.04-554.64%
2018NZ-$1.11-77.18%
2017NZ-$4.86-326.21%
2016NZ$2.15-134.19%
2015NZ-$6.28-371.34%
2014NZ$2.32-445.98%
2013NZ-$0.6732.88%
2012NZ-$0.50-82.07%
2011NZ-$2.81-817.9%
2010NZ$0.3912.73%
2009NZ$0.35-120.79%
2008NZ-$1.67-37.67%
2007NZ-$2.6839.64%
2006NZ-$1.9228.17%
2005NZ-$1.506.25%
2004NZ-$1.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
NZ$5.25-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$18.07-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.41-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$2.34-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ-$2.54 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.95-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.09-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$6.22-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$13.14-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA